Pharmacological Studies with Rescinnamine, a New Alkaloid Isolated from Rauwolfia serpentina
- 1 May 1954
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 86 (1) , 120-124
- https://doi.org/10.3181/00379727-86-21027
Abstract
Rescinnamine produced the typical pharmacological effects of R. serpentina: bradycardia, hypotension, sedation and characteristic alterations in cardiovascular responses. It caused augmentation of the pressor response to epinephrine, reversal of the pressor response to hypoxia, diminution of the pressor response to bilateral carotid occlusion, and blockade or reversal of the primary blood pressure rise elicited by faradization of the afferent vagus. The sedative effects of rescinnamine were demonstrated by gross observation in dogs, rats and mice, and by prolongation of pentobarbital induced sleeping time in mice. Rescinnamine produced marked eyelid ptosis in mice and a copious nasal discharge in rats. On a wt. basis, it appeared to be several times as potent as Rauwiloid and similar to reserpine. Rescinnamine is the second highly potent alkaloid derived from R. serpentina.Keywords
This publication has 4 references indexed in Scilit:
- Alterations in Cardiovascular Responses of the Dog Following Rauwiloid. An Alkaloidal Extract of Rauwolfia serpentinaExperimental Biology and Medicine, 1954
- Zur Pharmakologie des Reserpin, eines neuen Alkaloids ausRauwolfia Serpentina BenthCellular and Molecular Life Sciences, 1953
- Reserpin, der sedative Wirkstoff ausRauwolfia serpentina BenthCellular and Molecular Life Sciences, 1952
- CAROTID-OCCLUSION-PRESSOR REFLEX: INFLUENCE OF EXISTING MEAN ARTERIAL PRESSURE, OF ANESTHETICS AND OF GANGLIONIC- AND ADRENERGIC-BLOCKING DRUGSAmerican Journal of Physiology-Legacy Content, 1950